Synthesis of O-(<sup>18</sup>F-fluoroalkyl)-L-tyrosine as tumor imaging agents

TANG Ganghua1  TANG Xiaolan2   LUO Lei1 1

doi:null

您当前的位置：

首页 >

文章列表页 >

Synthesis of O-(¹⁸F-fluoroalkyl)-L-tyrosine as tumor imaging agents

更新时间：2021-03-12

- Synthesis of O-(¹⁸F-fluoroalkyl)-L-tyrosine as tumor imaging agents
- NUCLEAR TECHNIQUES Issue 8, (2003)
- 作者机构：
  
  1. 第一军医大学南方医院南方PET中心
  2. 华南农业大学理学院
  3. 第一军医大学南方医院南方PET中心,广州,510515
  4. ,广州,510642
- 作者简介：
- 基金信息：
- DOI：
  CLC： R914
- Published：01 August 2003
- 稿件说明：
移动端阅览
[1]唐刚华,唐小兰,罗磊.肿瘤显像剂O-(~(18)F-氟代正烷基)-L-酪氨酸的合成[J].核技术,2003(08):619-622.

TANG Ganghua1 TANG Xiaolan2 LUO Lei1 1. Synthesis of O-(¹⁸F-fluoroalkyl)-L-tyrosine as tumor imaging agents[J]. Nuclear techniques, 2003, (8): 619-622.
[1]唐刚华,唐小兰,罗磊.肿瘤显像剂O-(~(18)F-氟代正烷基)-L-酪氨酸的合成[J].核技术,2003(08):619-622. DOI：

TANG Ganghua1 TANG Xiaolan2 LUO Lei1 1. Synthesis of O-(¹⁸F-fluoroalkyl)-L-tyrosine as tumor imaging agents[J]. Nuclear techniques, 2003, (8): 619-622. DOI：

摘要

O-（2-18F-氟代乙基）-L-酪氨酸（FET）和O-（3-18F-氟代丙基）-L-酪氨酸（FPT）由两步法制备。18F-分别与二对甲苯磺酸乙二酯（TsOCH2CH2OTs）和二对甲苯磺酸丙二酯（TsOCH2CH2CH2OTs）发生亲核取代反应

生成对甲苯磺酸-2-18F-氟代乙酯（18F CH2CH2OTs）和对甲苯磺酸-3-18F-氟代丙酯（18FCH2CH2CH2OTs）

后两者再分别与L-酪氨酸二钠反应生成FET和FPT

总反应时间小于90 min。终产物FET和FPT用乙腈沉淀法分离纯化

未校正总放化产率分别为4.7%和8%。用HPLC法分离纯化

未校正总放化产率分别为20%和30%。FET和FPT注射液放化纯度大于95%

各质量控制指标符合放射性药物质量要求。

Abstract

O-(2-18F-Fluoroethyl)-L-tyrosine (FET) and O-(3-18F-fluoropropyl)-L-tyrosine (FPT) were prepared by a two-step reaction. First

nucleophilic fluorination reaction of 18F-fluoride with 1

2-di (4-methylphenylsulfonyloxy) ethane (TsOCH2CH2OTs) and 1

3-di(4-methylphenylsulfonyloxy) propane (TsOCH2CH2CH2OTs) gave 2-18F-1-(4- methylphenylsulfonyloxy) ethane (18FCH2CH2OTs) and 3-18F-1-(4-methylphenylsulfonyloxy) propane (18FCH2CH2CH2 OTs)

respectively. Then

18F-fluoroalkylation of L-tyrosine di-sodium salt formed FET and FPT respectively

with the whole synthesis time of less than 90 min. Purification of resultant FET and FPT by acetonitrile precipitation gave an overall radiochemical yield of 4.7% and 8% with no decay correction

and purification by HPLC gave an overall radiochemical yield of 20% and 30% with no decay correction

respectively. The radiochemical purity of FET and FPT injection was above 95%

and all quality parameters met the quality requirements of radiopharmaceuticals.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

TLC investigation of the radiochemical purity of copper[⁶⁴Cu] chloride solution

Quality assurance and quality control of neutron activation analysis for determination of elements in lunar soil samples returned by Chang'E-5 mission

Guidance on quality control of nuclear medicine in Yangtze River Delta region during regular epidemic prevention and control period of the novel coronavirus pneumonia

Evaluation and improvement of acceleratior's flatness and symmetry by six sigma capability and control technology

Fully automated synthesis of ¹⁸F-FDG by acidic hydrolysis on domestic module

Related Author

WANG Xiaoming

CHEN Mengyi

WU Fuhai

WEN Kai

ZHAO Hailong

ZHOU Jiajun

LI Hongyu

JIN Xiangchun

Related Institution

High Tech of Atom Co. Ltd.

China Institute of Atomic Energy

Department of Nuclear Medicine, Huashan Hospital, Fudan University

Department of Nuclear Medicine, Fudan University Pudong Medical Center

Zhejiang Nuclear Medicine Quality Control Center

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：881077 Visits Today：604

⁰

Synthesis of O-(18F-fluoroalkyl)-L-tyrosine as tumor imaging agents

DOI：

摘要

Abstract

关键词

Keywords

references

Synthesis of O-(¹⁸F-fluoroalkyl)-L-tyrosine as tumor imaging agents